Moreover, the glutathione synthesis inhibitor, BSO, decreases both CD3+ and CD8+ cells by 50% and 75% respectively, suggesting that tumor infiltrating lymphocytes are particularly sensitive to glutathione deprivation. Here, CD8A is linked to neoplasm.